『Introducing drug-anti-body conjugates』のカバーアート

Introducing drug-anti-body conjugates

Introducing drug-anti-body conjugates

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

Dr Lizanne Langenhoven details how knowing the subtype of breast cancer determines treatment, and introduces the new drug-antibody conjugates for HER2-positive breast cancer.

Dr Lizanne Langenhoven is a clinical and radiation oncologist at Panorama Mediclinic and forms part of a multi-disciplinary unit of excellence in the treatment of breast cancer at the Panorama Centre for Surgical Oncology. Facebook · Twitter · Instagram · LinkedIn
まだレビューはありません